The NHC is an independent statutory body charged with prioritising new and existing health technologies and making recommendations to the Minister of Health.

The New Zealand Government has asked that all new diagnostic and treatment (non-pharmaceutical) services, and significant expansions of existing services, are to be referred to the NHC.

The Committee also provides advice on what technologies are obsolete or no longer providing value for money for New Zealanders.

Latest news

  • 15 May 2015

    The National Health Committee (NHC) has reviewed an Evidence Update on percutaneous Left Atrial Appendage Occlusion (LAAO) for the prevention of stroke in non-valvular atrial fibrillation (AF) and a consultation is now being undertaken to ensure that this captures all relevant new evidence and that this has been correctly interpreted by the NHC.

  • 13 April 2015

    A referral for assessment of Intraoperative Radiotherapy (IORT) interventions available for breast cancer was put forward as part of the 2013/14 referral round.  This resulted in a Tier 2 assessment to explore the uses of IORT, which cancer types are highest priorities for further assessment and

  • 13 April 2015

    Age-related macular degeneration (AMD) is the leading cause of blindness in New Zealand in those aged over 50, accounting for half of all cases.